INVEGA 150 MG 1 PREFILLED SYRINGE

Used for: Treat schizophrenia and schizoaffective disorder in adts Reduce the risk of relapse in patients with schizophrenia who have responded to paliperidone palmitate Directions: Invega Sustenna is given by intramuscar injection by a healthcare professional The initial dose is 150 mg on day 1 and 100 mg on day 8 The recommended monthly maintenance dose is 75 mg; some patients may benefit from lower or higher doses within the recommended range of 25 to 150 mg Pack size: 1 prefilled syringe containing 1.5 mL of Invega Sustenna 150 mg Active ingredient: Paliperidone palmitate Dosage: The initial dose is 150 mg on day 1 and 100 mg on day 8 The recommended monthly maintenance dose is 75 mg; some patients may benefit from lower or higher doses within the recommended range of 25 to 150 mg